Autopsy report · NCT03365076
Exercise for Improving Prostate Oxygenation in Prostate Tumors (Exipox)
Cause of deathSlow enrollment
“Slow inclusion rate due to patients operated before intervention is implementable”
Life of this trial
- Registered 7 months before it started.
- Ran for about 4 years 8 months before it stopped.
- 1 participant enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- University Hospital of North Norway
- Sponsor type
- University, hospital or other
- Conditions
- Prostate Cancer; Physical Activity; Hypoxia
- Interventions
- Physical activity
- Participants
- 1
- Sites
- 1
- Countries
- Norway
Trials that died the same way
- Cetrotide Treatment Optimization
“Due to limited rate of patient inclusion” - Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism
“Due to slow inclusion of patients” - PET / CT With 18F-FDG: Does it Optimize the I 123-MIBG Imaging Results in the Search for Discriminating Factors for the Implementation of an Implantable Defibrillator?
“Inclusion rate too slow / infeasible.” - Brazilian and Italian Evaluation of Safety Using Tacrolimus-eluting Stent With Short-term Dual Antiplatelet Regimen
“slow inclusion, due to difficulties in obtaining the patients consent for the 2 months invasive follow-up, as required by protocol design.” - Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE)
“The rate of inclusion is too low to hope to reach the target of 800 patients. 59 patients were included, and their data will not meet the research objectives. The sponsor has decided to prematurely stop inclusions on January 13, 2022.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.